Dextroamphetamine and dexamethasone suppression test prediction of desipramine response

Baseline DST results may be devoid of prognostic value, but posttreatment nonsuppression of cortisol on the DST is strongly associated with poor outcome. Persistent nonsuppression may reflect a partially treated index episode or identify sicker patients who are unresponsive to treatment. The findings reiterate the importance of studying biological measures in relation to multiple validators of psychiatric illness beyond cross-sectional diagnosis.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Dextroamphetamine and dexamethasone suppression test prediction of desipramine response

Cited by 4 publications

References 11 publications

Predictors of antidepressant treatment outcome in melancholia: psychosocial, clinical and biological indicators

Predictors of antidepressant treatment outcome in melancholia: psychosocial, clinical and biological indicators

Biomarkers as predictors of treatment response to tricyclic antidepressants in major depressive disorder: A systematic review

The DST as a predictor of outcome in depression: a meta-analysis

Contact Info

Product

Resources

About